HOME › DRUGS › FRUQUINTINIB
ACTIVE SUBSTANCE / INN

FRUQUINTINIB

Brand name(s): FRUZAQLA, Fruzaqla
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Colorectal Neoplasms
NDA217564
ACTIVE SUBSTANCE
Fruquintinib
REGULATORS
FDA · EMA
SPONSORS / MAH
TAKEDA PHARMS USA, Takeda Pharmaceuticals International AG Ireland
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
FRUZAQLANDA217564TAKEDA PHARMS USAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FruzaqlaTakeda Pharmaceuticals International AG IrelandAuthorised20/06/2024Colorectal Neoplasms

FULL INTELLIGENCE ON FRUQUINTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →